RxDoctor Payments Data

Jeffrey Miller, MD

Thoracic Surgery (Cardiothoracic Vascular Surgery) · Atlanta, GANPI 1740246586

Payments from drug & device makers

What this record shows

The money is spread across several categories — travel and lodging (40.9%), food and beverage and consulting fees — rather than concentrated in one kind of arrangement. 12 manufacturers reported payments, led by Medtronic at 55.1% of the total. Reporting peaked in 2023 at $3,594 and has fallen 85.9% since, to $508 in 2025.

$7,744in general payments, 2019–2025

Across 53 payments — averaging $146.12 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Medtronic$4K
  • AbbVie$2K
  • Abiomed$477
  • Edwards Lifesciences$325
  • Davol Inc.$89
  • Abbott$75
  • plus $233 from 6 others
$875,374in research payments, 2019–2025

Across 78 payments — averaging $11,223 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.

  • AbbVie$572K
  • Medtronic$300K
  • Atricure, Inc.$3K

What the payments were for

  • Consulting fees$1,30017%
  • Speaking & faculty fees$85011%
  • Travel & lodging$3,16841%
  • Food & beverage$2,42731%

General payments by program year

19
20
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$7,744 in reported general payments places this provider in the 55th percentile of 144 thoracic surgery (cardiothoracic vascular surgery) providers in Georgia.

See all thoracic surgery (cardiothoracic vascular surgery) providers in Georgia

Medicare billing

Part B allowed, 2024
$258,433
Medicare patients
180
Services billed
491

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
EliquisApixaban36$22,829
Doxycycline Monohydrate26$368
Oxycodone Hcl61$343
Diltiazem 24hr Er (Cd)Diltiazem Hcl20$283
ClopidogrelClopidogrel Bisulfate36$278
Amiodarone Hcl19$244
Atorvastatin Calcium38$207
Metoprolol Tartrate63$190
Famotidine15$126
Potassium Chloride23$124
Furosemide31$92
Tramadol Hcl26$52
Carvedilol12$38

Paid to pharmacies, not to this prescriber.

Other thoracic surgery (cardiothoracic vascular surgery) in Atlanta

See the full list for Georgia

Where these figures come from

Is this you, or does something look wrong? →